Quest Diagnostics Inc vs Utilities Select Sector SPDR Fund — how do they compare? Quest Diagnostics Inc trades at $204.84 (market cap $22.80B), while Utilities Select Sector SPDR Fund trades at $45.9. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while Utilities Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| DGX | XLU | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | — |
52-Week High | $216.02 | $47.73 |
52-Week Low | $166.42 | $40.99 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
XLU trades at $45.72, up 0.68% today, with technical indicators showing a bullish trend from moving averages while oscillators remain neutral. The ETF benefits from growing electricity demand driven by AI data centers and clean energy transitions, positioning utilities as both defensive and growth-oriented investments. Recent news highlights XLU's role in powering AI infrastructure, with top holdings securing long-term power agreements with major tech firms.
Outlook remains positive due to structural power demand growth, though risks include regulatory changes and grid capacity constraints. Wall Street sentiment is bullish with strong institutional interest, but investors should monitor interest rate sensitivity and execution of capital expenditure plans for new power generation assets.
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →